Reps. Tonko, Gibbs Introduce Bipartisan Bill to Lower Prescription Drug Costs for American Consumers
April 27, 2021
April 27, 2021
WASHINGTON, April 27 -- Rep. Paul D. Tonko, D-New York, issued the following news release on April 26, 2021:
Representatives Paul D. Tonko (D-NY) and Bob Gibbs (R-OH) today introduced the Star Rating for Biosimilars Act, bipartisan legislation that directs the U.S. Department of Health & Human Services (HHS) to evaluate Medicare plans based on whether or not cost-saving biosimilars are available to enrollees.
Biosimilar drugs are clinically equivalent forms of biolo . . .
Representatives Paul D. Tonko (D-NY) and Bob Gibbs (R-OH) today introduced the Star Rating for Biosimilars Act, bipartisan legislation that directs the U.S. Department of Health & Human Services (HHS) to evaluate Medicare plans based on whether or not cost-saving biosimilars are available to enrollees.
Biosimilar drugs are clinically equivalent forms of biolo . . .